Skip to content

Current ratio at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.9×-0.2×
TFX
TeleflexTFX
2.6×+0.3×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.3×-0.8×
IAR
Integra LifeSciencesIART
3.4×+2.2×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
PDE
Pro-Dex, Inc.PDEX
3.7×+0.9×

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity

Where this comes from

Calculated from Utah Medical Products’s reported figures.

Based on the most recent quarter.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's current ratio?
Utah Medical Products (UTMD) reported current ratio of 28.6× in Q1 2026.
How has Utah Medical Products's current ratio changed year-over-year?
Utah Medical Products's current ratio increased by 28.5% year-over-year, from 22.3× to 28.6×.
What is the long-term trend for Utah Medical Products's current ratio?
Over 5 years (2020 to 2025), Utah Medical Products's current ratio has grown at a 18.0% compound annual growth rate (CAGR), from 16.4× to 37.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.